KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Cash & Equivalents (2016 - 2026)

Intuitive Surgical has reported Cash & Equivalents over the past 18 years, most recently at $2.0 billion for Q1 2026.

  • Quarterly Cash & Equivalents fell 23.33% to $2.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, down 23.33% year-over-year, with the annual reading at $3.4 billion for FY2025, 63.3% up from the prior year.
  • Cash & Equivalents was $2.0 billion for Q1 2026 at Intuitive Surgical, down from $3.4 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $3.6 billion in Q3 2023 and troughed at $1.1 billion in Q1 2022.
  • The 5-year median for Cash & Equivalents is $2.6 billion (2025), against an average of $2.5 billion.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 134.2% in 2023 and later crashed 32.08% in 2024.
  • Tracing ISRG's Cash & Equivalents over 5 years: stood at $1.6 billion in 2022, then soared by 75.19% to $2.8 billion in 2023, then dropped by 25.55% to $2.1 billion in 2024, then skyrocketed by 63.3% to $3.4 billion in 2025, then crashed by 40.42% to $2.0 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $2.0 billion, $3.4 billion, and $2.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.